Germany· DE-A57-abdbfacb48151222
Phenprogamma
A phenprocoumon product containing phenprocoumon, registered in Germany by Wörwag Pharma Gmbh & Co. Kg. The same ATC class is registered in 7 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Phenprocoumon is registered in 7 of 19 countries.
Countries holding a registration under ATC B01AA04 (phenprocoumon), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 3 of them publish a price we can compare per daily dose
Phenprocoumon · ATC B01AA04
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Germany
- Netherlands
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of phenprocoumon costs, country by country.
Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Phenprocoumon · price per daily dose (3 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.45
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Phenprocoumon
- Manufacturer
- Wörwag Pharma Gmbh & Co. Kg
- Country
- Germany (DE)
- ATC code
- B01AA04
- ATC class
- Phenprocoumon
- Defined daily dose
- 3 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
82 interactions on record for phenprocoumon.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Phenprocoumon · interactions on record
82 records
82 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Phenprocoumon in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandMarcoumar, TablettenViatris Pharma GmbH
- NetherlandsFenprocoumon Sandoz 3 mg, tablettenSandoz B.V.
- BelgiumMarcoumar 3 mgViatris Healthcare
- United KingdomMarcoumar 3mg tabletsImported (Germany)
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Austria · Marcoumar
- Belgium · Marcoumar
- Luxembourg · Marcoumar
- Netherlands · Fenprocoumon Sandoz, Marcoumar
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e81b9969-cd4b-4a4c-81a1-dc84214cf5db GET /v1/drugs/e81b9969-cd4b-4a4c-81a1-dc84214cf5db?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Phenprocoumon",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about phenprocoumon.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.